Can methotrexate replace steroids for immunotherapy joint pain?
NCT ID NCT06001125
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested methotrexate, a common arthritis drug, for treating joint pain and swelling caused by cancer treatments that boost the immune system. The goal was to help patients stop taking steroids like prednisone, which have many side effects. The trial was stopped early after enrolling only 27 people, so we don't have clear answers on how well methotrexate works for this condition.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Methotrexate
What this could lead to
If it worked, methotrexate could offer an alternative to long-term steroids for managing joint pain from cancer immunotherapy, potentially reducing side effects.
What could go wrong
The trial was terminated early with only 27 participants, so results are limited. Methotrexate also has its own side effects and may not work for everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cross Cancer Institute
Edmonton, Canada